Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), Budapest, Hungary.
Oral Solids Development, Janssen R&D, Beerse, Belgium.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul;12(4):e1611. doi: 10.1002/wnan.1611. Epub 2019 Dec 20.
Recently, electrospinning (ES) of fibers has been shown to be an attractive strategy for drug delivery. One of the main features of ES is that a wide variety of drugs can be loaded into the fibers to improve their bioavailability, to enhance dissolution, or to achieve controlled release. Besides, ES is a continuous technology with low energy consumption, which can make it a very economic production alternative to the widely used freeze drying and spray drying. However, the low production rate of laboratory-scaled ES has limited the industrial application of the technology so far. This article covers the various ES technologies developed for scaled-up fiber production with an emphasis on pharmaceutically relevant examples. The methods used for increasing the productivity are complied, which is followed by a review of specific examples from literature where these technologies are utilized to produce oral drug delivery systems. The different technologies are compared in terms of their basic principles, advantages, and limitations. Finally, the different downstream processing options to prepare tablets or capsules containing the electrospun drug are covered as well. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies.
最近,纤维的静电纺丝(ES)已被证明是一种有吸引力的药物输送策略。ES 的主要特点之一是可以将多种药物加载到纤维中,以提高其生物利用度、增强溶解或实现控制释放。此外,ES 是一种具有低能耗的连续技术,这使得它成为广泛使用的冷冻干燥和喷雾干燥的非常经济的生产替代方案。然而,实验室规模的 ES 生产速率低,限制了该技术的工业应用。本文涵盖了为规模化纤维生产开发的各种 ES 技术,重点介绍了与制药相关的例子。本文还总结了提高生产力的方法,并回顾了文献中利用这些技术生产口服药物输送系统的具体例子。根据其基本原理、优点和局限性对不同的技术进行了比较。最后,还涵盖了制备含有静电纺丝药物的片剂或胶囊的不同下游处理选择。本文属于以下类别:治疗方法和药物发现 > 新兴技术。